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Abstract: A random mutagenesis of the arabinofuranosyl hydrolase Araf51 has been run in 
order to access to efficient biocatalysts for the synthesis of alkyl arabinofuranosides. The 
mutants were selected on their ability to catalyze the transglycosylation reaction of p-
nitrophenyl α-L-arabinofuranoside (pNP-Araf) used as a donor and various aliphatic alcohols 
as acceptors. This screening strategy underlined 5 interesting clones, each one corresponding 
to one acceptor. They appeared to be much more efficient in the transglycosylation reaction 
compared to the wild type enzyme whereas no self-condensation or hydrolysis products could 
be detected. Moreover, the high specificity of the mutants towards the alcohols for which they 
have been selected validates the screening process. Sequence analysis of the mutated enzymes 
revealed that, despite their location far from the active site, the mutations affect significantly 
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the kinetics properties as well as the substrate affinity of these mutants towards the alcohol 
acceptors in the transglycosylation reaction. 
Keywords: Furanosides, Transglycosylation, Random mutagenesis, Furanosidase 
 
1. Introduction 
One of the current needs in chemical research is the development of greener and more eco-friendly 
reactions. The glycosylation is an example thereof, being one of the most important and difficult 
reactions for biomolecules synthesis. Indeed, it still remains a challenge in chemistry requiring 
multiple reaction steps and the use of various protecting groups. In Nature there are multiple enzymes 
as glycosyltransferases, polysaccharide lyases and glycosidases able to assemble or cleave easily the 
glycosidic bond with high regioselectivity.1 Nowadays, biotechnological approaches are recognized as 
powerful tools for the synthesis of glycoconjugates and improving biocatalyst efficiency seems to be 
one of the most promising approaches.2-7 Moreover it is noteworthy that the chemical synthesis of 
arabinofuranosides with a high degree of stereocontrol and without any pyranosidic forms, suffers 
from a lack of generality. For instance the synthesis of alkyl arabinofuranosides is generally obtained 
from the key intermediates per-O-protected furanoses.8-10 However, biocatalyzed furanosylation has 
been recently developed and its versatility was further extended to the preparation of non-natural 
furanosyl-containing conjugates (for a review, see reference11). Indeed, glycosidases are good 
candidates in comparison to other enzymes, thanks to their stability, ease of production and low-cost 
of substrates which can be bio-sources. A recent example of directed evolution was applied to the β-
glycosidase of Thermus thermophilus in order to increase its ability to synthesize oligopyranosides vs. 
its hydrolytic activity.12-14 To achieve these results, Koné et al. developed a high-throughput digital 
imaging screening methodology to detect transglycosidase mutants in E. coli cells.14  
Herein, we adapted and completed this kind of screening to improve arabinofuranosyl 
transglycosylation with the aim to apply it to a wide range of aliphatic alcohols (Scheme 1). As a 
model reaction, we chose to synthesize alkyl α-L-arabinofuranosides which are simple molecules with 
diverse properties and potential uses. Depending on the nature of the alkyl chain, they find 
  
applications as immunostimulating agents or antiparasitic drugs.15-17 More generally, the alkyl 
pyranosidic counterparts act as chemical building blocks for further derivatization and industrial 
preparation of alkyl polyglycosides.18,19 
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Scheme 1. Enzymatic synthesis of alkyl α-L-arabinofuranosides. 
 
In this context, we performed random mutagenesis on the α-L-arabinofuranosidase (Araf51) from 
Clostridium thermocellum in an attempt to improve the transglycosylation activities for the synthesis 
of alkyl α-L-arabinofuranosides. For the selection of suitable variants, a screening in two steps has 
been developed. The initial one, directly on plates, allowed colony selection of mutants with good 
hydrolytic activity on an Araf-containing chromogenic substrate. Indeed in order to maintain the 
physical quality of the agar gels and cells viability, the presence of alcohols as acceptors was excluded 
for this first screening step. The second one assessed the transglycosylation activities towards the 
convenient alcohol acceptor of the previous selected enzymes by 96-well spectrophotometry. In this 
approach, one of the main objectives was to obtain mutants with high selectivity towards nucleophilic 
alcohols: one specific mutant for one specific acceptor.  
  
 
2. Results and discussion 
2.1. Identification of mutants with improved transglycosylation abilities. 
The thermostable arabinofuranosyl hydrolase, Araf51, naturally removes α-(12), α-(13) and α-
(15)-linked L-arabinofuranosyl units from arabinans and arabinoxylans. To the best of our 
knowledge, this enzyme belongs to the only arabinofuranosidase family (GH51) showing the ability to 
catalyze transglycosylation reactions. In addition, Araf51 has been described several times for its 
substrate versatility as it recognizes arabinofuranosides as well as galactofuranosides.17,20-23 
Preliminary experiments showed the ability of the Araf51 wild type (wt) to transglycosylate pNP-Araf 
to small aliphatic alcohol in order to obtain alkyl α-L-arabinofuranosides.24 However, the activity 
strongly decreased when acceptors contain more than 3 carbons in their chain. With the aim to 
improve the transglycosylation activity towards aliphatic alcohols, mutants were thus created by 
random mutagenesis and selected from a simple screening procedure.  
Firstly, a library of mutated Araf51 genes has been generated by error prone PCR and cloned into 
pCR® 2.1-TOPO® vector. After cell transformations, E. coli BL21 DE3 clones were spread on LB 
plates for the screening. This latter consisted in a first selection of positive colonies overexpressing an 
active Araf51. During this step, the colonies were platted on LB media containing IPTG and 1.5 mM 
of 5-bromo-indolyl α-L-arabinofuranosyl.25 This molecule is hydrolyzed by the Araf51 releasing a 
blue air-oxidized di-indolyl compound. In this way, the colonies staining in blue expressed enzymes 
successfully cloned which still recognize the arabinofuranosyl moiety as donor. Ideally, mutants that 
tend to favor transglycosylation were supposed to perform slow aglycon release in the absence of a 
suitable acceptor and therefore display a pale blue staining. Nevertheless, a low expression level of 
some mutated enzymes could also result in a pale coloration. Also, the selection of all the blue 
colonies was performed and the transglycosylation properties of the resulting enzymes assayed.  
This first step allowed us to select more than 120 colonies for further expression of the mutated 
enzymes. The corresponding cell free extracts were heated at 70 °C to remove most of the E. coli 
derived proteins and also confirmed the thermostability of the selected mutants. In the second step of 
  
the screening procedure, each enzyme was tested in the presence of pNP-Araf and an alcohol in order 
to evaluate their transglycosylation ability (T) over hydrolysis potential (H) (Scheme 2). UV-
measurements were performed during the initial time where the deglycosylation of the glycosyl-
enzyme intermediate is the rate-limiting step. If the transglycosylation is favored, the initial speed rate 
in these conditions should be higher than the one during the hydrolysis. The initial reaction rates were 
determined thanks to the release of p-nitrophenol (405 nm). For each cell free extract, two types of 
reaction were performed, in presence and absence of alcohol acceptor. The alcohol volume was up to 
25% (v/v) to limit the presence of water, and so to favor as much as possible the target 
transglycosylation. DMSO was added to the reaction mixture as an optimized solubility factor for 
aliphatic alcohol. Reactions were performed at pH 8 to ensure maintaining the phenolate form of the 
leaving group and thus proper UV-visible monitoring. A range of linear alcohols were tested from 
methanol to n-hexanol as well as i-propanol, allylic alcohol and solketal.  
 
Scheme 2. Araf51-catalyzed transglycosylation with pNP-Araf as donor and alcohols as acceptors. 
 
To easily reveal interesting enzymes, the initial speed rates obtained (Vi) were normalized with the 
one corresponding to the wild type. Then, a ratio R was calculated correlating directly to the increase 
of activity in presence of the acceptor (Equation 1). 
R=   H+T

 (Equation 1) 
  
with ViH+T corresponds to the initial rate in presence of alcohol, and ViH to the initial rate without 
alcohol.  
 
For each alcohol tested, around twenty mutants showed positive activation with R value above 1. In 
order to detect these mutants with potentially better transglycosylation than the wild type, analytic 
time course reactions were performed and conversions (Table 1) determined by NMR spectroscopy: 
the protons corresponding to the pNP group are up-field shifted when released, and the appearance of 
a new anomeric proton from the product was clearly observed (see supplementary materials). On this 
basis, we focused our attention on five mutants. Then preparative reactions were performed, and the 
transglycosylation products were isolated by column chromatography (Table 1). The alkyl resulting α-
L-arabinofuranosides were characterized by 1H and 13C NMR analysis. These data were in accordance 
with previously recorded results for compounds 1-5, 926-28 and new furanosides 6-8 were fully 
described in the experimental part. 
 
Table 1. Conversions and yields by transglycosylation using Araf51 wt and selected mutants for 
different alcohol acceptors. 
Entry Acceptor Araf51 wt  Mutant   Improvementc 
  Conversiona 
(%) 
Time 
(min) 
Conversiona 
(%) 
Time 
(min) 
Yieldb 
(%) 
 
1 MeOH 95 60 - - -  
2 EtOH 90 60 - - -  
3 n-PrOH 85 120 96 (M20) 60 60 + 13% 
4 i-PrOH 30 120 38 (M22) 60 30 + 27% 
5 Solketal 38 120 - - -  
6 AllOH 76 120 - - -  
7 n-BuOH 42 50 92 (M12) 20 68 + 119% 
8 n-PentOH 72 120 96 (M60) 120 80 + 33% 
  
9 n-HexOH 37 120 94 (M57) 120 71 + 154% 
aConversion in transglycosylated product; bIsolated yield; cWas obtained as 100x(Conversion mutant – 
Conversion wt)/Conversion wt. 
 
Data from Table 1 firstly showed that moderate (i-propanol, solketal, n-butanol, n-hexanol) to 
excellent (methanol, ethanol) conversions in transglycosylated derivatives were generally obtained 
using the wild type biocatalyst but long reaction times were required (up to 2 hours). Secondly, it is 
important to note that no autocondensation product has been observed, probably due to the high 
concentration of alcohol acceptor that favored the desired transglycosylation. Subsequently, the 
mutation procedure of Araf51 wt enabled the isolation of 5 mutants with significant improved 
transglycosylation activities for n- propanol, i- propanol, n- butanol, n-pentanol, and n- hexanol 
(entries 3, 4, 7, 8, 9, respectively). In comparison to the native enzyme, the engineered biocatalysts 
were all more promising in term of reaction time and conversion in tranglycosylation, with 
improvement from + 13% for M20 (n-propanol, entry 3) to + 154% for M57 (n- hexanol, entry 9). As 
an example, time course evolution between the wild type biocatalyst and the M20 mutant was given in 
figure 1. Unfortunately, the proposed protocol did not afford improved biocatalyst for solketal and 
allyl alcohol. Nevertheless, under the transglycosylation conditions performed with the selected 
mutants, hydrolysis of the resulted arabinofuranosides was not observed, even over 120 minutes and 
after total consumption of the substrate. Finally, no other transglycosylation by-products 
(autocondensation) were observed, so that the targeted α-L-arabinofuranosides were specifically 
formed, confirming the diastereoselectivity of the mutants according to the glycosidic bond, whatever 
the nature of the biocatalyst. 
 
 
  
Figure 1. Time course of transglycosylation into propyl α-L-arabinofuranoside (black) from pNP-Araf 
(grey) by a) Araf51 wt and b) M20. 
 
In order to evaluate the selectivity towards the aliphatic acceptor thanks to the mutated biocatalysts, 
transglycosylation reactions were performed with other structurally close alcohols (Table 2). It 
appeared that the mutants showed significantly better transglycosylation ability for the alcohol for 
which they were selected than for other acceptors. For instance, M20 mutant was particularly efficient 
and selective for n-propanol. 
 
Table 2. Selectivity of the mutated enzymes (% of transglycosylation conversion). 
Entry Mutant EtOH n-PrOH i-PrOH n-BuOH n-PentOH n-HexOH 
1 M20 20 96 4 10   
2 M22  26 38 25   
3 M12  19 
 92 35  
4 M60    65 96 79 
5 M57     65 94 
 
2.2. Kinetic characterization and mutation identification of the selected enzymes 
Finally, the kinetic parameters of the different mutants were determined under hydrolysis conditions of 
pNP-Araf at 25 °C and pH 8 (50 mM Tris HCl buffer). Whereas Araf 51 is a thermophilic enzyme 
with Topt around 82 °C, the parameters were determined at 25 °C for practical reasons, as previously 
reported.29 The data presented in table 3 compares the values obtained with the Araf51 wt to the ones 
calculated for the selected enzymes. Most of the new biocatalysts showed lower Km by comparison 
with the wild type, especially for M20 and M22. Furthermore, kcat values for the mutants were also 
lower than that for the wild type Araf51. 
 
Table 3. Determination of Araf51 wt and selected mutants kinetic parameters for the hydrolysis 
reaction of pNP-Araf (pH 8, 50 mM of Tris HCl buffer, at 25 °C). 
  
Enzyme Km (mM) kcat (s-1) kcat/Km 
Araf51 wt 0.34 ± 0.08 143 ± 5 420 
M20 0.07 ± 0.02 133 ± 6.4 1900 
M22 0.07 ± 0.01 20.9 ± 1.2 298 
M12 0.26 ± 0.10 93.8 ± 12 360 
M60 0.17 ± 0.06 118 ± 8.7 694 
M57 0.16 ± 0.04 73.6 ± 4.7 460 
 
On a structural point of view, the crystal structure of the wild type enzyme has been previously solved 
(PDB file: 2C7F) and showed that two essential catalytic residues are required for the hydrolysis 
reaction were assigned as the acid/base residue Glu173 and the nucleophile Glu292. Moreover, 
structural information was also obtained from the co-crystallised of the inactive mutant E173A form of 
Araf51 with natural arabinotriose and arabinoxylobiose.29 These studies suggest little specificity for 
the exact orientation of the aglycone in the +1 subsite due to flexible conformation adopted by Trp178 
which stacks against the aglycone sugar unit. The sequence analysis of the mutants from this study 
revealed from one to six mutations (Table 4, see also supplementary data). It clearly appeared that the 
mutations were neither within the active site nor close to it. Nevertheless, concerning the biocatalyzed 
synthesis of the target alkyl arabinofuranosides, we expected that the alkyl chains could fit the entry of 
the common GH51 (β/α)8 barrel domain located at the extremity of the -1 subsite. Despite the location 
of the mutated sites, far from the active site, these mutations seemed to significantly affect the kinetics 
properties with regards to substrate affinity and transglycosylation reaction activity. 
 
Table 4. Identified mutations. 
Enzyme Mutations 
M20 R51G, V105L, T220S, S268T, A348S 
M22 P392S 
M12 K115T 
  
M60 V105L, D134G, T220S, S268T, A348S, E405D 
M57 V105L, T220S, S268T 
 
3. Conclusion  
Thanks to the coupling of random mutagenesis method conducted on the arabinofuranosyl hydrolase 
Araf51 and an efficient screening, we have obtained five mutants able to catalyze the transfer of an 
arabinofuranosyl entity to various aliphatic alcohols. In comparison to the wild type enzyme, these 
new biocatalysts improved the transglycosylation conversions up to 96%. Additionally, the procedure 
used in the study yielded new biocatalysts with increased transglycosylation abilities and selectivity 
closely depending on the nature of the acceptor for which they were screened. This strategy was 
efficient with the aim of synthesizing valuable chemical building blocks such as alkyl α-L-
arabinofuranosides. Additional benefits mutations in these rationally designed enzymes appeared to be 
distant from the active site. Further directed evolution experiments targeted on these observed 
mutations are now required in order to study the properties and catalytic abilities of the generated 
enzymes and to accurately understand the involvement of each modified site.  
 
4. Experimental 
4.1. Expression and purification of Araf51 and mutant derivatives 
Plasmid pET28a (+) (Novagen) containing Araf51 wild type from Clostridium thermocellum29 and 
kanamycin resistance genes was provided by Prof G. Davies, University of York, U. K. Plasmid 
pCR®2.1-TOPO® (3.9 kb) from Invitrogen contains encoding mutated enzymes genes as well as 
ampicillin and kanamycin resistance genes. These plasmids were under the control of T7 promoter. 
The enzymes were produced in Escherichia coli BL21 DE3 cells (Invitrogen) cultured in LB 
(Lysogeny broth) plates containing 0.1 mM of the corresponding selective agent at 37 °C. 10 millitres 
of LB medium supplemented with antibiotic were inoculated with one single positive colony E. coli 
BL21 (DE3) and incubated overnight at 37 °C, 250 rpm. That was subsequently used to prepare 1% 
inoculum (200 mL LB + antibiotic, 250 rpm, 37 °C). Cells were grown to mid-exponential phase 
[Absorbance, A550: 0.7] at which point i-propyl -D-thiogalactopyraoside (IPTG) was added to a final 
  
concentration of 1.0 mM and the cultures were incubated for 14 h at 37 °C. After centrifugation (20 
min, 4000 rpm, 4 °C), the cells were resuspended in 50 mM Tris HCl buffer pH 8 and sonicated (3 × 
10 s) for another centrifugation (30 min, 20000 rpm, 4 °C), the supernatant was heated at 70 °C for 15 
min to remove a major amount of proteins and centrifuged again at 20000 rpm for 30 min. Protein 
concentrations were determined by the Bradford method.30 The purity of His-tagged Araf51 was 
confirmed by SDS-PAGE after Ni-NTA agarose affinity chromatography (Novagen, USA).  
 
4.2. Determination of Araf51 kinetic parameters 
The kinetic parameters Km and kcat of Araf51 were quantified in triplicate by incubation of the enzyme 
(10 µL of  1 mg/mL) with different concentrations of p-nitrophenyl -L-arabinofuranoside (6 to 0.02 
mM) in 50 mM Tris HCl buffer pH 8 at 25 °C. The release of p-nitrophenol was measured at 405 nm 
during 5 min (Microplates Spectrophotometer PowerWave XS/XS2, BioTek). The kinetic parameters 
were determined by calculations using GOSA software with repeatability.  
 
4.3. Random mutagenesis 
Random mutagenesis was performed by GeneMorph II Random Mutagenesis kit (Stratagene) using 
mutagenic PCR. The open reading frame encoding Araf51 was amplified using the primers:  
 forward T7 Promoter TACGACTCACTATAGGGGAA and reverse T7 Promoter 
GCTAGTTATTGCTCAGCGGT (Strategy 1); 
 forward T7 Promoter TACGACTCACTATAGGGGAA and reverse T7 Promoter 
GTGAGTCGTATTAATTTCGCGGT (Strategy 2). 
For low mutation number (mutation frequency 0 – 4.5 mutations / kb), 500 ng of the initial target 
DNA were mixed with 250 ng of each primer, 1 µL of 40 mM dNTP mix (final concentration of 800 
µM each), 5 µL of 10 × Mutazyme II reaction buffer and 1 µL of Mutazyme II DNA polymerase (2.5 
U/µL) completed to 50 µL with H2O. The reaction was thermocycled as follows: one hot start cycle 
(95 °C, 2 min) then 10 cycles: first the denaturing step (95 °C, 30 s), the hybridation step (60 °C, 30 s) 
and the elongation step performed for 1min/kb (72 °C, 7 min or 10 min); and finally one cycle at 
72 °C for 10 min. Only for the second strategy, mutagenesis PCR products were directly cloned into a 
  
plasmid vector using the TOPO TA Cloning® Invitrogen protocol. The fresh PCR product (2 µL) was 
mixed with the different reagents provided in the TOPO TA Cloning® Invitrogen kit: 1 µL salt 
solution, 1 µL pCR®2.1-TOPO® vector and H2O was added up to a final volume of 6 µL. The 
reaction was incubated for 5 min at room temperature (22-23 °C).  
 
4.4. Screening of mutants 
The blue colonies were selected and cultivated in 5 mL LB media containing 0.1 mM kanamycin LB 
media. The enzymes were purified as previously described and analyzed for their transglycosylation 
activities. As previously, protein concentration was estimated by Bradford method. Enzyme assays 
were performed to compare transglycosylation activities (presence of the alcohol acceptor) to 
hydrolytic activities (absence of the alcohol). Mutants and Araf51 wt enzymes were incubated in pH 8 
Tris HCl 50 mM buffer with 20 mM pNP-Araf, 20% (v/v) DMSO, with or without 25% (v/v) alcohol 
for a final volume of 140 µL at 50 °C. The final concentration in enzyme necessarily reached 0.017 
mg/mL, thus the collected volume having to be adapted to each attempt following the determination of 
the initial concentration by the Bradford method. The release of p-nitrophenol was measured at 405 
nm during 5 min (Microplate Spectrophotometer Powerwase XS/XS2, Biotek) and data evaluated with 
Gen5 Data Analysis Software (Biotek). The initial activities of the enzyme and mutated enzymes were 
determined using the monitoring of UV curves of the enzymatic assays. This enabled to compare the 
slope between Araf51 wt and the one of the mutants with or without the presence of alcohol acceptors, 
and highlighted the mutants of interest. Indeed, the mutated enzymes presenting a higher slope than 
the one of the Araf51 wt, in presence of alcohol, showed higher reaction activations, meaning that 
transglycosylation was preferred.  
 
4.5. Analytical scale of transglycosylation reactions, NMR kinetics 
Enzymatic reactions were run from 20 mM pNP-Araf (4.3 mg) and 200 µL of alcohol acceptor 
incubated in pH 8 Tris HCl 50 mM buffer with 160 µL of DMSO. The enzyme preparation was added 
(a final concentration of 0.017 mg/mL is required) to the solution, and finally completed to a final 
volume of 800 µL and maintained at 50 °C during 3 h. Aliquots (100 µL) of the enzymatic reaction 
  
mixture were withdrawn at several times and directly freezed with liquid nitrogen. After complete 
lyophilization, samples were solubilized in 500 µL of CD3OD to enable the analysis by NMR. 
Transglycosylation activities using pNP-Araf as glycosyl donor were determined by 1H NMR. By 
monitoring the decrease of the pNP-Araf signal (aromatic protons =8.21 ppm and/or anomeric proton 
=5.66 ppm) and the release of p-nitrophenol (aromatic protons =8.12 ppm) corresponding to both 
the hydrolysis and the transglycosylation of the donor, the residual starting material can easily be 
quantified. The transglycosylation products were visualized by the emergence of the anomeric proton 
signal of the furanoside and/or the signal of the alkyl group protons. By reporting the relation between 
the proton signals, the resulting conversions were determined. 
 
4.6. General procedure for the synthesis of alkyl arabinofuranosides in a preparative scale 
Experiments were performed in 50 mM Tris HCl buffer, pH 8 at 50 °C in the presence of pNP-Araf 
(30 mg, 0.11 mM), 1.4 mL of alcohol and 1.12 mL of DMSO in a total reaction volume of 5.6 mL. 
Araf51 wild type or mutated was added to a final concentration of 0.017 mg/mL and the reaction was 
performed at 50 °C during the optimal duration determined at the analytical scale experiment. Then 
the mixture was concentrated under reduced pressure and the reaction products were separated by 
column chromatography on silica gel (AcOEt/AcOH/H2O, 50:1:1) affording the desired product. 
 
4.7. Purification and analysis of synthetic alkyl arabinofuranosides 
Thin layer chromatography (TLC) analysis were conducted on E. Merck 60 F254 Silica Gel non 
activated plates and compounds were visualized by UV (254 nm), or a 5% solution of H2SO4 solution 
in EtOH containing orcinol, followed by heating. For column chromatography, Si 60 (40-63 µm) 
Silica Gel was used. NMR spectra were recorded on a Bruker spectrometer ARX (400 MHz for 1H and 
100 MHz for 13C). Chemicals shifts are expressed in  units (ppm). Chemical shifts are calculated in 
Hertz and pattern abbreviations are as follows: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), dd (double doublet)...The HRMS were measured with a MicrO-Tof-Q 2 (Bruker) equipped 
with electrospray and APCI ionization sources, two quadrupole-orthogonal accelerators and reflection 
  
time-of-flight analyzer, or a Q-tof 2 (Waters) equipped with electrospray ionization source, two 
quadrupole-orthogonal accelerators and reflection time-of-flight analyzer.  
 
4.8. n-Pentyl α-L-arabinofuranoside (6) 
n-Pentyl α-L-arabinofuranoside 6 was obtained according to the described general procedure 
for transglycosylation by incubation of n-pentanol in the presence of the Araf51, and was 
isolated in 66% yield (16.1 mg) after purification by column chromatography.1H NMR 
(CD3OD):  4.84 (d, 1H, J1,2 = 2.0 Hz, H-1), 3.94 (dd, 1H, J2,3 = 4.0 Hz, H-2), 3.92-3.89 (m, 
1H, H-4), 3.82 (dd, 1H, J3,4 = 6.4 Hz, H-3), 3.73 (dd, 1H, J4,5 = 3.2 Hz, J5a,5b = 12.0 Hz, H-
5a), 3.71 (dt, 1H, JCH2,CH2 = 10.0 Hz, JCH2,CH2 = 6.4 Hz, OCH2CH2), 3.62 (dd, 1H, J4,5b = 5.2 
Hz, H-5b), 3.41 (dt, 1H, JCH2,CH2 = 9.6 Hz, JCH2,CH2= 6.8 Hz, OCH2CH2), 1.61-1.57 (m, 2H, 
OCH2CH2), 1.36-1.34 (m, 4H, CH2CH2CH3), 0.92 (t, 3H, JCH2,CH3= 7.2 Hz, CH3).13C NMR 
(CD3OD):  109.4 (C-1), 85.1 (C-4), 83.6 (C-2), 78.7 (C-3), 68.8 (OCH2CH2), 63.0 (C-5), 
30.4 (OCH2CH2), 29.5 (CH2CH2CH3), 23.5 (CH2CH3), 14.4 (CH3). HRMS (ESI+): m/z calcd 
for C10H20O5Na [M+Na]+ m/z 243.1208 ; found, m/z 243.1676. 
 
4.9. n-Hexyl α-L-arabinofuranoside (7) 
n-Hexyl α-L-arabinofuranoside 7 was obtained according to the described general procedure 
for transglycosylation by incubating n-hexanol in the presence of the Araf51 wt. It was 
isolated in 71% yield (18.5 mg) after purification by column chromatography. 1H NMR 
(CD3OD):  4.84 (d, 1H, J1,2 = 2.0 Hz, H-1), 3.94 (dd, 1H, J2,3 = 4.0 Hz, H-2), 3.92-3.90 (m, 
1H, H-4), 3.82 (dd, 1H, J3,4 = 6.4 Hz, H-3), 3.74 (dd, 1H, J4,5 = 3.2 Hz, J5a,5b = 12.0 Hz, H-
5a), 3.71 (dt, 1H, JCH2,CH2 = 6.8 Hz, JCH2,CH2 = 9.6 Hz, OCH2CH2), 3.62 (dd, 1H, J4,5b = 5.6 
Hz, H-5b), 3.41 (dt, 1H, JCH2,CH2 = 9.6 Hz, JCH2,CH2 = 6.4 Hz, OCH2CH2), 1.60-1.57 (m, 2H, 
OCH2CH2), 1.35-1.32 (m, 6H, CH2CH2CH2CH3), 0.91 (t, 3H, JCH2,CH3 = 6.8 Hz, CH3). 13C 
  
NMR (CD3OD):  109.4 (C-1), 85.1 (C-4), 83.6 (C-2), 78.7 (C-3), 68.8 (OCH2CH2), 63.0 (C-
5), 32.8 (OCH2CH2), 30.7 (CH2CH2CH2CH3), 26.9 (CH2CH2CH3), 23.7 (CH2CH3), 14.4 
(CH3). HRMS (ESI+): calcd for C11H22O5Na [M+Na]+ m/z 257.1365; found, m/z 257.1915. 
 
4.10. 3-O--L-arabinofuranosyl-O-isopropylidene-sn-glycerol (8) 
The desired furanoside 8 was obtained according to the general procedure for transglycosylation by 
incubation of solketal in the presence of the Araf51 wt. After chromatographic purification, it was 
isolated in 36% yield (10.5 mg). 1H NMR (CD3OD):  4.92 (d, 1H, J1,2 = 1.6 Hz, H-1), 4.31-
4.27 (m, 1H, CH2CHCH2), 4.05 (ddd, 1H, J = 2.4 Hz, J = 6.8 Hz, J = 8.4 Hz, O-
1CH2CHCH2O), 3.99 (dd, 1H, J2,3 = 3.6 Hz, H-2), 3.92-3.90 (m, 1H, H-4), 3.84 (dd, 1H, J3,4 = 
6.0 Hz, H-3), 3.78-3.74 (m, 2H, O-1CH2CH-CH2, O-1CH2), 3.71 (dd, 1H, J4,5a = 5.2 Hz, J5a,5b 
= 12 Hz, H-5a), 3.64 (dd, 1H, J4,5b = 5.6 Hz, H-5b), 3.50-3.47 (m, 1H, O-1CH2), 1.38 (s, 3H, 
CH3), 1.32 (s, 3H, CH3).13C NMR(CD3OD):  109.7 (C-1), 85.7 (C-4), 83.1 (C-2), 78.8 (C-3), 
75.9 (CH), 69.1 (O-1CH2CH), 67.6 (O-1CH2CHCH2), 63.0 (C-5), 27.0 (CH3), 25.6 (CH3). 
HRMS (ESI+): calcd for C11H20O7Na [M+Na]+ m/z 287.1107; found, m/z 287.0985. 
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